SAVANNAH TANNER: Open Payments
NPI 1700291648 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 13 payments from 7 companies in 2025. Trend: 2023 $589 · 2024 $338 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $220 |
| ABIOMED | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| Amgen Inc. | 2 | $40 |
| Baxter Healthcare | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: WAINUA, LEQVIO, Repatha, Hillrom - Cardiac Ambulatory Monitor, CAMZYOS, AMVUTTRA, FARXIGA.
Industry payments across NM — which companies pay providers there.
